A validated UHPLC-MS/MS method for rapid determination of senicapoc in plasma samples

The clinically tested KCa3.1 channel blocker, senicapoc, has been proven to have excellent pharmacological properties and prior clinical trials found it to be safe for use in patients with sickle cell anaemia. Currently, several preclinical projects are aiming to repurpose senicapoc for other indica...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Pharm Biomed Anal
Main Authors: Sørensen, Lambert K., Petersen, Asbjørn, Granfeldt, Asger, Simonsen, Ulf, Hasselstrøm, Jørgen B.
格式: Artigo
語言:Inglês
出版: Elsevier B.V. 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869607/
https://ncbi.nlm.nih.gov/pubmed/33626443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2021.113956
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍